Norsk Hydro
16.1.2026 08:00:00 CET | Globenewswire | Press release
Norsk Hydro: Invitation to Hydro's fourth quarter results 2025
Norsk Hydro: Invitation to Hydro's fourth quarter results 2025
Hydro's fourth quarter results 2025 will be released at 07:00 CET (01:00 EDT, 06:00 UTC/GMT) on February 13, 2025. The integrated annual report 2025 will be released the same day at 08:00 CET (02:00 EST, 07:00 UTC/GMT). The quarterly report, presentation and annual report will be available on hydro.com at the same time as the releases.
President and CEO Eivind Kallevik, and Executive Vice President and CFO Trond Olaf Christophersen, will host a webinar in English at 08:30 CET the same day. There will be a Q&A session directly after the presentation. There will be no physical presentation or press conference.
To join the webinar and ask questions, use the link to the webcast page.
The webcast is powered by Zoom. No login or registration in advance is required.
It is also possible to log in using the dial-in option:
Norway +47 2400 4736
London, UK +44 330 088 5830
New York, US +1 929 205 6099
Meeting ID: 920 8167 1402
We advise you to investigate in advance if your company has any restrictions on using the Zoom platform.
Investor contact:
Baard Erik Haugen
+47 92497191
erik.haugen@hydro.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Trifork Group AG26.8.2026 17:43:32 CEST | Press release
51/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Scandinavian Tobacco Group A/S26.8.2026 17:20:00 CEST | Press release
Scandinavian Tobacco Group: Interim Report 1 January – 30 June 2026: Progressing with Focus2030 and Full Year 2026 Guidance maintained
Aegon Ltd.26.8.2026 15:50:00 CEST | Press release
Aegon has filed Shareholder Circular for proposed US redomiciliation
ODDIFACT26.8.2026 15:27:59 CEST | Press release
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Værdipapirfonden Independent Invest II26.8.2026 15:03:40 CEST | Pressemeddelelse
Fusion af afdelinger i Værdipapirfonden Independent Invest II
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom